Molecular Detection

Bioneer has been awarded US Patent No. 8,513,399, "Primers for PCR amplification comprising basic parts within the primer sequences."
Hyun Bae Kim, Seong Youl Kim, Jun Mo Gil, Hae Joon Park, and Han Oh Park are named as inventors.

Roche last week said that it has received US Food and Drug Administration approval of a new pre-analytical instrument that integrates primary tube handling into its Cobas molecular testing platform.

By Ben Butkus
Molecular Detection said this week that it has completed a $1.5 million financing to advance commercialization of its Detect-Ready molecular diagnostic panels for detecting sepsis and gastrointestinal diseases.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Molecular diagnostic firm Molecular Detection today said that it has completed a $1.5 million financing round to advance its tests for detecting sepsis and gastrointestinal diseases.

NetBio has been awarded US Patent No. 8,018,593, "Integrated nucleic acid analysis."
Eugene Tan, Heung Lam, Valery Bogdanov, Gregory Kellogg, John Wright, Ulrich Thomann, and Richard Selden are named as inventors on the patent.

MDI's Detect-Ready MRSA panel is the only marketed PCR-based screen proven to be able to discriminate between MRSA, MSSA, and other related bacteria, the firm said.

Detect-Ready MRSA is a qualitative real-time PCR in vitro diagnostic test marketed in the European Union and Australia and in late-stage development in the US.

The company's test, called Detect-Ready, uses real-time PCR to amplify and evaluate multiple gene targets to detect and distinguish between samples containing MRSA, MSSA, and mixed populations of bacteria.

Molecular Detection's Detect-Ready MRSA Panel, Idaho Technology's FilmArray Respiratory Panel, Seegene's Magicplex RV Panel Real-time Test

Pages

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.